Case Study: a mid-size pharmaceutical company accelerates orphan drug reformulation with Kymanox

A Kymanox Case Study

Complete Product Reformulation for Mid-Size Pharmaceutical​

The customer, a mid-size pharmaceutical company, faced the challenge of completely overhauling the formulation and manufacturing process for an orphan drug while strictly adhering to FDA standards. They needed to accelerate development for timely market access and required an integrated regulatory strategy to minimize approval hurdles. They partnered with Kymanox for its CMC & Pharma Science, Regulatory Affairs, and Technical Services.

Kymanox designed an innovative formulation and developed a robust, validated manufacturing process. The solution included qualifying production equipment and validating analytical methods. Kymanox successfully manufactured registration batches that met all quality and regulatory requirements, achieving this from concept to registration in a 12-month timeline. This enabled the client to efficiently achieve its reformulation goals, supporting improved patient compliance for the orphan drug indication and ensuring a seamless transition to commercial production.


View this case study…

Kymanox

58 Case Studies